Single treatment for both Plasmodium vivax and Plasmodium falciparum malaria Permission received to conduct Phase III clinical trials for pediatric formulation Gurgaon, India,: Ranbaxy Laboratories Limited (Ranbaxy) today announced that the company has received approval from the Central Drugs Standard Control Organisation (CDSCO), Government of India to manufacture and market Synriam … [Read more...]